Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 11, 2011

View Archived Issues

Tetraphase Pharmaceuticals describes multiple novel tetracyclines

GlycoVax discloses preclinical data on its proprietary glycoprotein vaccines

First-in-human data presented on risperidone-ISM formulation

Japanese team identifies new biomarker of pulmonary emphysema

Twelve-month data presented from IMPACT-DCM trial

MedImmune completes phase II tralokinumab trial

New chemokine CCR3 receptor antagonists patented by Axikin Pharmaceuticals

Pfizer synthesizes novel ghrelin receptor antagonists/inverse agonists

Janssen Pharmaceutica presents new DPP-I inhibitors

New JAK1 inhibitors claimed by Incyte

Pulmagen Therapeutics reports novel neutrophil elastase inhibitors

United Therapeutics subsidiary receives NIH grant to support glycobiology program

Inovio and VGX enter agreement to develop hepatitis vaccines

Dynavax reports immunogenicity data from phase III Heplisav trial

Cellceutix adds new indication to IND application for Kevetrin

Lilly seeks approval for new olanzapine formulation in Japan

Pharmasset expands ELECTRON trial

Targacept begins phase IIb trial of AZD-3480

Depomed launches once-daily Gralise

NanoCarrier and LFB Biotechnologies enter research collaboration

Insmed provides update on Arikace

Asahi Kasei Pharma to study transdermal patch formulation of Teribone using Zosano technology

Daval International reports phase II data on Aimspro

Takeda discontinues ramelteon development in Europe

Ligand Pharmaceuticals and Chiva Pharmaceuticals form global Fablyn agreement

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...